A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.

Seiichiro MitaniShigenori KadowakiAzusa KomoriChihiro KondohIsao OzeKyoko KatoToshiki MasuishiKazunori HondaYukiya NaritaHiroya TaniguchiMasashi AndoTsutomu TanakaMasahiro TajikaKei Muro

Published in: Advances in therapy (2020)

UMIN Clinical Trial Registry (UMIN000016416).

Keyphrases

phase ii study
open label
clinical trial
locally advanced
neoadjuvant chemotherapy
phase ii
phase iii
placebo controlled
double blind
study protocol
metastatic colorectal cancer
rectal cancer
radiation therapy
squamous cell carcinoma